Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment.
about
The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer PatientsPerceived Stress Levels, Chemotherapy, Radiation Treatment and Tumor Characteristics Are Associated with a Persistent Increased Frequency of Somatic Chromosomal Instability in Women Diagnosed with Breast Cancer: A One Year Longitudinal StudyThe active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cellsEffects of CYP2D6 and CYP3A5 polymorphisms on tamoxifen and its metabolites in Thai breast cancer patients.Expanding public-private collaborations to enhance cancer drug development: a report of the Institute of Medicine's workshop series, "Implementing a National Cancer Clinical Trials System for the 21st Century"Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen.Limited predictive value of achieving beneficial plasma (Z)-endoxifen threshold level by CYP2D6 genotyping in tamoxifen-treated Polish women with breast cancer.Association of CYP2D6*10 (c.100C>T) polymorphisms with clinical outcome of breast cancer after tamoxifen adjuvant endocrine therapy in Chinese populationApplication of Mice Humanized for CYP2D6 to the Study of Tamoxifen Metabolism and Drug-Drug Interaction with AntidepressantsPKC/MEK inhibitors suppress oxaliplatin-induced neuropathy and potentiate the antitumor effects.A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen.The effect of CYP2D6 *10 polymorphism on adjuvant tamoxifen in Asian breast cancer patients: a meta-analysis.Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients.Variations in plasma concentrations of tamoxifen metabolites and the effects of genetic polymorphisms on tamoxifen metabolism in Korean patients with breast cancer.Tamoxifen Directly Inhibits Platelet Angiogenic Potential and Platelet-Mediated Metastasis.The Effect of Undaria pinnatifida Fucoidan on the Pharmacokinetics of Letrozole and Tamoxifen in Patients With Breast Cancer.
P2860
Q26782449-42792DF0-BD8F-4784-800A-1F00CD98ABB4Q28383479-8F726A4C-B0C3-4740-A638-063E245D1321Q28546094-19AE47FF-1672-4CFD-95B5-3AD148C1AB98Q33589336-0D32992E-A9F3-4CC0-8491-24F4DA8FDD72Q34458056-41816395-379C-469F-8C2C-F9B44DB083A6Q35168556-F9FDEF7E-04A1-466B-B18A-1EE8C3DA2B8AQ35732619-0E754883-1148-4602-BC33-88C0693A36DBQ37228037-F2C91A54-FFEF-4E09-A2E3-B4FFF154087DQ37540176-04566A0A-9E56-4AAC-84B1-4574FFD78557Q38937300-AA5F65C2-F304-47BE-B59E-6AB0254A79B5Q40639052-D2B9BC2B-94B4-402F-BC4A-AE45F0B03285Q45987663-E62AB7FC-1FFF-46FC-BD6A-C7F89B300F97Q47099651-8FDF6F98-131B-418A-990D-409951C32BA1Q47155427-C0BC6F44-297F-44D3-AE5D-6D45F2DABFF0Q51155744-4C7B542A-462F-437A-B12A-ABFA9BC2E00AQ54964664-53726860-E167-4352-B1FA-6A879F6BBCF6
P2860
Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum concentrations of tamoxi ...... during steady-state treatment.
@en
Serum concentrations of tamoxi ...... during steady-state treatment.
@nl
type
label
Serum concentrations of tamoxi ...... during steady-state treatment.
@en
Serum concentrations of tamoxi ...... during steady-state treatment.
@nl
prefLabel
Serum concentrations of tamoxi ...... during steady-state treatment.
@en
Serum concentrations of tamoxi ...... during steady-state treatment.
@nl
P2093
P2860
P50
P1476
Serum concentrations of tamoxi ...... during steady-state treatment.
@en
P2093
Ernst A Lien
Gunnar Mellgren
Jennifer Gjerde
Vidar M Steen
P2860
P2888
P304
P356
10.1007/S10549-013-2677-9
P407
P577
2013-09-01T00:00:00Z